Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in Burkina Faso: a protocol for a randomized open label trial

BACKGROUND: Plasmodium falciparum malaria remains a major public health concern in sub-Sahara Africa. Seasonal malaria chemoprevention (SMC) with amodiaquine + sulfadoxine-pyrimethamine is one of the most important preventive interventions. Despite its implementation, the burden of malaria is still...

Descripción completa

Detalles Bibliográficos
Autores principales: Sondo, Paul, Tahita, Marc Christian, Ilboudo, Hamidou, Rouamba, Toussaint, Derra, Karim, Tougri, Gauthier, Ouédraogo, Florence, Konseibo, Béatrice Marie Adélaïde, Roamba, Eli, Otienoburu, Sabina Dahlström, Kaboré, Bérenger, Kennon, Kalynn, Ouédraogo, Kadija, Zongo, Wend-Timbe-Noma Arlette Raïssa, Bocoum, Fadima Yaya, Stepniewska, Kasia, Dhorda, Mehul, Guérin, Philippe J., Tinto, Halidou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791765/
https://www.ncbi.nlm.nih.gov/pubmed/35081964
http://dx.doi.org/10.1186/s13690-022-00800-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791765/
https://www.ncbi.nlm.nih.gov/pubmed/35081964
http://dx.doi.org/10.1186/s13690-022-00800-x

Ejemplares similares